Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
April 16, 2026
Todos Medical Appoints Ilanit Halperin, CPA as Corporate Controller
July 7, 2021
Related Post
-
-
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
April 15, 2026
-
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 14, 2026
-
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
April 13, 2026